See every side of every news story
Published loading...Updated

CIREL study finds comparable overall survival between indication for irinotecan-TACE in colorectal liver metastases - Interventional News

Summary by Interventional News
Results from CIREL—the largest, pan-European, prospective study of irinotecan-eluting transarterial chemoembolization (TACE) for colorectal liver metastases (CRLMs), show a comparably long median overall survival (OS) when used as salvage therapy and “promising” hepatic progression-free survival (HPFS) when used with systemic therapy or thermal ablation as a post-inductive or consolidation therapy. The study, published in European Society for Me…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Interventional News broke the news in on Thursday, March 6, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.